Glassia (alpha1-proteinase inhibitor (Human)) / Takeda, Kamada  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Glassia (alpha1-proteinase inhibitor (Human)) / Takeda
NCT01651351: GLASSIA Infusion Rate Study

Completed
4
30
US
Alpha1-proteinase inhibitor, GLASSIA, Placebo: Human albumin 2.5%
Baxalta now part of Shire
Alpha1-antitrypsin Deficiency, Healthy Volunteers
01/13
01/13

Download Options